熱門資訊> 正文
内部人士购买后，Cabaletta Bio股价攀升
2026-01-22 21:08
- Cabaletta Bio (CABA) shares climbed 11% on Thursday following recent insider purchases. Michael Gerard, the company’s General Counsel, bought 6,600 shares of Cabaletta Bio (CABA) on January 21, 2026, totaling $14,979.
- Chang David J., Chief Medical Officer, purchased 8,800 shares of the company at an average price of $2.26 per share.
- Binder Gwendolyn, President of Science & Technology, acquired 11,312 shares at an average price of $2.1891, totaling 31,312 shares owned.
More on Cabaletta Bio
- Cabaletta Bio, Inc. (CABA) Presents At Citi Annual Global Healthcare Conference 2025 Transcript
- Seeking Alpha’s Quant Rating on Cabaletta Bio
- Historical earnings data for Cabaletta Bio
- Financial information for Cabaletta Bio
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
